Ask a Question

Prefer a chat interface with context about you and your work?

Bayesian Adaptive Randomized Trial Design for Patients With Recurrent Glioblastoma

Bayesian Adaptive Randomized Trial Design for Patients With Recurrent Glioblastoma

To evaluate whether the use of Bayesian adaptive randomized (AR) designs in clinical trials for glioblastoma is feasible and would allow for more efficient trials.